Overview

Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the therapeutic efficacy and safety of cholic acid in subjects with identified inborn errors of bile acid synthesis.
Phase:
Phase 3
Details
Lead Sponsor:
Retrophin, Inc.
Travere Therapeutics, Inc.
Treatments:
Bile Acids and Salts
Cholic Acids